Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus

Vaccine

Volumn 29, Issue 11, 2011, Pages 2178-2186

  Hwang, Seon Do ^a   Kim, Hyun Soo ^a   Cho, Sung Whan ^a   Seo, Sang Heui ^a  

^a Chungnam National University   (South Korea)

Author keywords

H5N1; Influenza virus; Vaccine

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CHICKEN; HEMAGGLUTINATION INHIBITION TEST; IMMUNITY; IMMUNIZATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LUNG; NONHUMAN; NOSE CAVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRACHEA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CLOACA; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; REASSORTANT VIRUSES; TRACHEA; VACCINES, INACTIVATED;

EID: 79951810040     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.013     Document Type: Article

References (42)

1. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56:152-179.
2. Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005, 79:2814-2822.
3. Fouchier R.A., Schneeberger P.M., Rozendaal F.W., Broekman J.M., Kemink S.A., Munster V., et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004, 101:1356-1361.
4. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279:393-396.
5. Xu X., Subbarao, Cox N.J., Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 1999, 261:15-19.
6. Shortridge K.F., Zhou N.N., Guan Y., Gao P., Ito T., Kawaoka Y., et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998, 252:331-342.
7. Claas E.C., Osterhaus A.D., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351:472-557.
8. Lee C.W., Suarez D.L., Tumpey T.M., Sung H.W., Kwon Y.K., Lee Y.J., et al. Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J Virol 2005, 79:3692-3702.
9. Mase M., Tsukamoto K., Imada T., Imai K., Tanimura N., Nakamura K., et al. Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology 2005, 332:167-176.
10. Wan X.F., Ren T., Luo K.J., Liao M., Zhang G.H., Chen J.D., et al. Genetic characterization of H5N1 avian influenza viruses isolated in southern China during the 2003-04 avian influenza outbreaks. Arch Virol 2005, 150:1257-1266.
11. Li K.S., Guan Y., Wang J., Smith G.J., Xu K.M., Duan L., et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004, 430:209-213.
12. Chen H., Smith G.J., Zhang S.Y., Qin K., Wang J., Li K.S., et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005, 436:191-192.
13. Liu J., Xiao H., Lei F., Zhu Q., Qin K., Zhang X.W., et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005, 309:1206.
14. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines. http://www.who.int/csr/disease/avian_influenza/guidelines/201002_H5_H9_VaccineVirusUpdate.pdf.
15. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO, http://www.who.int/csr/disease/avian_influenza/guidelines/nomenclature/en/.
16. van der Goot J.A., van Boven M., Stegeman A., van de Water S.G., de Jong M.C., Koch G. Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology 2008, 382:91-97.
17. Sasaki T., Kokumai N., Ohgitani T., Sakamoto R., Takikawa N., Lin Z., et al. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Vaccine 2009, 27:5174-5177.
18. Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., et al. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 2006, 351:303-311.
19. Lee C.W., Senne D.A., Suarez D.L. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 2004, 22:3175-3181.
20. Song H., Nieto G.R., Perez D.R. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 2007, 81:9238-9248.
21. Steel J., Burmakina S.V., Thomas C., Spackman E., García-Sastre A., Swayne D.E., et al. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 2008, 26(4):522-531.
22. Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., Ahmed L.E., et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 2009, 4:e6509.
23. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006, 80:1959-1964.
24. Mingxiao M., Ningyi J., Zhenguo W., Ruilin W., Dongliang F., Min Z., et al. Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 2006, 24:4304-4311.
25. Steel J., Lowen A.C., Pena L., Angel M., Solórzano A., Albrecht R., et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 2009, 83:1742-1753.
26. Pavlova S.P., Veits J., Keil G.M., Mettenleiter T.C., Fuchs W. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 2009, 27:773-785.
27. Pavlova S.P., Veits J., Mettenleiter T.C., Fuchs W. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine 2009, 27:5085-5090.
28. Steensels M., Bublot M., Van Borm S., De Vriese J., Lambrecht B., Richard-Mazet A., et al. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 2009, 27:646-654.
29. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81:150-158.
30. Qiao C., Jiang Y., Tian G., Wang X., Li C., Xin X., et al. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus. Antiviral Res 2009, 81:234-238.
31. Römer-Oberdörfer A., Veits J., Helferich D., Mettenleiter T.C. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 2008, 26:2307-2313.
32. Toro H., Tang D.C., Suarez D.L., Zhang J., Shi Z. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine 2008, 26:2640-2646.
33. Wood J.M., Kawaoka Y., Newberry L.A., Bordwell E., Webster R.G. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Dis 1985, 29:867-872.
34. Liu M., Wood J.M., Ellis T., Krauss S., Seiler P., Johnson C., et al. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 2003, 314:580-590.
35. Sandbulte M.R., Jimenez G.S., Boon A.C., Smith L.R., Treanor J.J., Webby R.J. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007, 4:e59.
36. Murakami S., Iwasa A., Iwatsuki-Horimoto K., Ito M., Kiso M., Kida H., et al. Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model. Vaccine 2008, 26:6398-6404.
37. Forrest H.L., Khalenkov A.M., Govorkova E.A., Kim J.K., Del Giudice G., Webster R.G. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. Vaccine 2009, 27:4187-4195.
38. Vijaykrishna D., Bahl J., Riley S., Duan L., Zhang J.X., Chen H., et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog 2008, 4:e1000161.
39. Dung Nguyen T., Vinh Nguyen T., Vijaykrishna D., Webster R.G., Guan Y., Malik Peiris J.S., et al. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg Infect Dis 2008, 14:632-636.
40. Smith G.J., Fan X.H., Wang J., Li K.S., Qin K., Zhang J.X., et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci USA 2006, 103:16936-16941.
41. Lamm M.E. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997, 51:311-340.
42. Mbawuike I.N., Pacheco S., Acuna C.L., Switzer K.C., Zhang Y., Harriman G.R. Mucosal immunity to influenza without IgA: an IgA knockout mouse model. J Immunol 1999, 162:2530-2537.